Showing results (901-910 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|July 6, 2026
A first-in-human phase 1a study of LP-184, a tumor-site activated novel alkylating agent, in patients with advanced solid tumorsDaruka Mahadevan, Jay Parekh, Joseph T Beck, et al.Investigational New Drugs|July 17, 2026
The novel agent VP79s synergistically enhances venetoclax activity in multiple myeloma cellsYunlong Pei, Jiaxun Wang, Taylor Smith, et al.Investigational New Drugs|August 28, 2026
Influence of LGALS3 polymorphisms on chemotherapy-induced peripheral neuropathy in patients with metastatic pancreatic cancer treated with gemcitabine and nab-paclitaxel: an exploratory biomarker analysis of the GENESECT studyMasahiro Hatori, Daiki Tsuji, Kyoka Nagai, et al.Investigational New Drugs|August 28, 2026
Qishen Yiqi Dripping Pills ameliorate doxorubicin-induced cardiotoxicity: a study based on bioinformatics and experimental verificationJiangtao Wang, Jian Yu, Dong Cao, et al.Investigational New Drugs|September 15, 2026
Parthenolide enhances imatinib activity in gastrointestinal stromal tumor models through stress-associated apoptosisChuang-Ming Zheng, Longyi Piao, Zhenggen Piao, et al.Investigational New Drugs|June 8, 2001
Role of formulation vehicles in taxane pharmacologyL van Zuylen, J Verweij, A SparreboomInvestigational New Drugs|June 8, 2001
Progress in the development of alternative pharmaceutical formulations of taxanesB Nuijen, M Bouma, J H Schellens, et al.Investigational New Drugs|June 8, 2001
Drug interactions of paclitaxel and docetaxel and their relevance for the design of combination therapyL Vigano, A Locatelli, G Grasselli, et al.Investigational New Drugs|September 20, 2001
Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancerB Brockstein, B Samuels, R Humerickhouse, et al.Investigational New Drugs|September 20, 2001
Phase II trial of GM-CSF in advanced prostate cancerR Dreicer, W A See, E A KleinPageof 372